Product NDC: | 0049-2720 |
Proprietary Name: | Cardura |
Non Proprietary Name: | doxazosin mesylate |
Active Ingredient(s): | 8 mg/1 & nbsp; doxazosin mesylate |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, MULTILAYER, EXTENDED RELEASE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0049-2720 |
Labeler Name: | Roerig |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA021269 |
Marketing Category: | NDA |
Start Marketing Date: | 20050222 |
Package NDC: | 0049-2720-30 |
Package Description: | 30 TABLET, MULTILAYER, EXTENDED RELEASE in 1 BOTTLE (0049-2720-30) |
NDC Code | 0049-2720-30 |
Proprietary Name | Cardura |
Package Description | 30 TABLET, MULTILAYER, EXTENDED RELEASE in 1 BOTTLE (0049-2720-30) |
Product NDC | 0049-2720 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | doxazosin mesylate |
Dosage Form Name | TABLET, MULTILAYER, EXTENDED RELEASE |
Route Name | ORAL |
Start Marketing Date | 20050222 |
Marketing Category Name | NDA |
Labeler Name | Roerig |
Substance Name | DOXAZOSIN MESYLATE |
Strength Number | 8 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Adrenergic alpha-Antagonists [MoA],alpha-Adrenergic Blocker [EPC] |